Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults-Reference-Cited by-同舟云学术

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

Published:2022-07-21 Issue:7 Volume:5 Page:e2223090
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Eliakim-Raz Noa¹²,Stemmer Amos³,Ghantous Nassem¹²,Ness Asaf¹²,Awwad Muhammad¹²,Leibovici-Weisman Yaara¹²,Stemmer Salomon M.²⁴

Affiliation:

1. Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel

4. Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794465/eliakimraz_2022_ld_220148_1657735394.10522.pdf

Reference6 articles.

1. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged =60 years.;Eliakim-Raz;JAMA,2021

2. Assessment of 4 doses of SARS-CoV-2 messenger RNA–based vaccine in recipients of a solid organ transplant.;Kamar;JAMA Netw Open,2021

3. Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series.;Alejo;Transplantation,2021

4. Association of SARS-CoV-2 seropositive antibody test with risk of future infection.;Harvey;JAMA Intern Med,2021

5. Abbott. SARS-CoV-2 immunoassays. Accessed October 1, 2021. https://www.corelaboratory.abbott/int/en/offerings/segments/infectious-disease/sars-cov-2-

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers;Influenza and Other Respiratory Viruses;2024-08-27

2. Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects;Frontiers in Immunology;2024-01-26

3. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers;BMC Infectious Diseases;2024-01-17

4. Modeling of antibody responses to COVID-19 vaccination in patients with rheumatoid arthritis;Scientific Reports;2024-01-16

5. Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination;Vaccines;2023-12-28